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Abstract
Background: The transcriptome and its regulation bridge the genome and the phenome. Recent RNA-seq studies
unveiled complex transcriptomes with previously unknown transcripts and functions. To investigate the
characteristics of neural transcriptomes and possible functions of previously unknown transcripts, we analyzed and
compared nine recent RNA-seq datasets corresponding to tissues/organs ranging from stem cell, embryonic brain
cortex to adult whole brain.
Results: We found that the neural and stem cell transcriptomes share global similarity in both gene and
chromosomal expression, but are quite different from those of liver or muscle. We also found an unusually high
level of unannotated expression in mouse embryonic brains. The intronic unannotated expression was found to be
strongly associated with genes annotated for neurogenesis, axon guidance, negative regulation of transcription,
and neural transmission. These functions are the hallmarks of the late embryonic stage cortex, and crucial for
synaptogenesis and neural circuit formation.
Conclusions: Our results revealed unique global and local landscapes of neural transcriptomes. It also suggested
potential functional roles for previously unknown transcripts actively expressed in the developing brain cortex. Our
findings provide new insights into potentially novel genes, gene functions and regulatory mechanisms in early
brain development.
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Background
It is well known that total gene numbers are similar
among multicellular eukaryotes, and genome size does
not correlate with organism complexity, which differs
greatly in terms of development, physiology and beha-
vior among eukaryotes [1]. The transcriptome and its
regulation contribute significantly to eukaryotic diversity
in the aforementioned complexity. The Functional
Annotation of the Transcriptome of Mammalian Gen-
ome (FANTOM) projects (FANTOM 1-4) have demon-
strated the complexity of transcriptomes in several
aspects, including non-coding RNAs [2], antisense tran-
scription [2,3], regulated retrotransposon expression [4],
and alternative promoter usage, splicing and polyadeny-
lation [5].
Recent high-throughput RNA-seq [6] technologies
have provided unprecedented capability to analyze cellu-
lar, tissue-specific, or organismal gene activities across a
broad spectrum. It also revealed the transcriptomic
complexity during cell differentiation [7,8] and organ
development [9]. Furthermore, individuals of the same
species have transcriptomic differences such as expres-
sion variation among humans [10]. Another level of
transcriptomic complexities has been revealed by exten-
sive analysis of novel splicing variants from known
exons [7-11]. In addition, thousands of transcripts from
previously unannotated (non-exonic) genomic regions
have been reported [7,8,10-13]; they are either named
TUF (Transcripts of Unknown Function) [14] or unan-
notated TAR (Transcriptionally Active Region) [15].
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noncoding RNAs that function in embryonic stem cell
pluripotency and cell proliferation [16,17], while most
unannotated TARs have no known function.
It has been reported that undifferentiated human stem
cells have elevated expression of unannotated TARs
compared with differentiated neural progenitor cells [7].
Our recent study has also detected additional transcripts
from intergenic regions and introns in mouse embryonic
and neonatal brain cortices [9]. Mammalian neural
development is a complex process involving cell divi-
s i o n ,c e l ld i f f e r e n t i a t i o n ,c e l lm i g r a t i o n ,a x o ng u i d a n c e ,
synaptogenesis, and synaptic plasticity. The characteriza-
tion of stage specific unannotated TARs during early
brain development could provide clues regarding the
roles these unannotated TARs might play in determin-
ing neural fate and in regulating neuronal functions.
To further investigate the transcriptome dynamics
and to better understand the possible roles of unanno-
tated TARs in early neural development, we have ana-
lyzed the RNA-seq datasets from embryonic and
postnatal mouse brain cortices that we generated
recently [9], as well as seven additional RNA-seq data-
sets covering both neural and non-neural tissues
[7,18]. These nine transcriptome datasets include data
from human embryonic stem cell (hESC) and its sub-
sequently differentiated forms (N1, early initiation; N2,
neural progenitor; and N3, early glial-like cell) [7],
embryonic day 18 (E18) and postnatal day 7 (P7)
mouse brain cortices [9], and adult mouse brain
(AMB), liver (AML), and muscle (AMM) [18].
Through a systematic analysis of these nine datasets,
we found several unique characteristics of the transcrip-
tomes in early neural development. We found that,
although the genome was not as pervasively transcribed
as previously reported [19], most of the genomic regions
at 1 Mb resolution had detectable RNA-seq signals. We
also found that the transcriptomes from neural tissues
possessed several genome-wide characteristics resem-
bling those of stem cells. Interestingly, the E18 cortex
shows the highest level of unannotated transcript
expression compared to P7 and adult brains. Further-
more, the intronic unannotated transcripts are asso-
ciated with GO terms for neurogenesis, neural signaling
and negative regulation. Importantly, few of the unanno-
tated TARs in E18 and P7 cortices are connected with
known transcripts, suggesting potential novel functions
of these TARs during brain development.
Results and discussion
Mapping RNA-seq data from mouse developing brains
and other organs
To examine the genomic distribution of transcriptomic
reads, we mapped all RNA-seq data by the TopHat
software [20], which was designed to map RNA-seq data
with moderate IT (information technology) infrastruc-
ture. Embryonic, neonatal and adult mouse data were
mapped onto the mouse reference genome (UCSC
mm9, NCBI build 37) as described in the Methods sec-
tion. For comparison, adult mouse liver and muscle
R N A - s e qd a t aw e r ea n a l y z e di nt h es a m em a n n e r .
Human ESC and its differentiation data were mapped
o n t ot h eh u m a nr e f e r e n c eg e n o m e( U C S Ch g 1 9 ,N C B I
build 37). Only uniquely matched reads were further
analyzed. Because the amounts of data available for the
downstream analysis varied for different tissues (Table
1), the read count data were first normalized against the
available dataset size, measured in base pairs, for each
tissue. To accommodate differences in the details of
library preparation and sequencing procedures, we
adjusted for the sequencing quality in all data sets
according to the quality computation method of the
Illumina 1.3 pipeline. E18 and P7 RNA-seq data had the
largest percentage of mappable reads in this group,
approximately 60%, while other data sets had about 30%
mappable data. The AMB RNA-seq data had the largest
quantity, with more than 1,000 million mapped base
pairs.
Most 1-Mb genomic regions have transcriptional activity
with uneven distribution at a finer scale
D e s p i t ead a t a s e ts i z eu pt o1 , 0 0 0M b p( A M B ) ,o n l y
about 2% of the mouse genome had been mapped with
RNA-seq reads, unlike a previous report that suggested
am o r ep e r v a s i v e l yt r a n s c r i b e dg e n o m ef r o md e t a i l e d
analyses of ~1% of the human genome [19]. A recent
study using single- and paired-end RNA-seq and tiling
arrays also concluded that the genome is not as perva-
sively transcribed as previously reported [12]. Never-
theless, when the mouse genome was divided into 1
million base-pair long intervals, we observed that 85%
of the intervals had 100 or more detected RNA-seq
reads (Figure 1). However, the majority of chromo-
some regions of the 100 kb size had no detected tran-
scription, as illustrated for X-chromosome (Additional
file 1, Fig. S1). Whereas many regions showed tran-
scription at both the E18 and P7 stages, some regions
were specifically active in one of these stages, suggest-
ing that a selective set of genes are turned on and off
from embryonic to neonatal brain stages, consistent
with the previous finding of preferential expression of
several thousand genes at either one of these stages
[9]. Besides heterochromatin regions (centromeres and
telomeres), some large genomic regions with very low
annotated gene content had no detectable reads,
including several regions in chromosome 7 (Figure 1)
and the region in chromosome × from 26,000,000 to
32,000,000 bp (Additional file 1, Fig. S1).
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Page 2 of 22After further dividing the genome into 10 kb intervals,
most of the 10 kb intervals had no detected transcrip-
tion (Figure 2A). Most of the reads in highly expressed
intervals (> 1,000 RNA-seq reads) were mapped to
known exons. Among intervals with 1,000 to 10,000
detected reads, more intervals had intergenic transcripts
than intronic transcripts, with very few intervals having
all three types (exonic, intronic and intergenic) of tran-
scripts. For intervals with 100 or more RNA-seq reads,
there were 3 times more intervals expressing intronic
signal in E18 stage than in P7 stage. The E18 stage also
h a ds l i g h t l ym o r ei n t e r v a l swith intergenic transcripts
than the P7 stage, although the numbers of intervals
with exonic transcripts were similar between the two
stages (Figure 2B).
W ef o u n dt h a te x p r e s s i o nl e vel was positively corre-
lated with the exon contents of a given interval. The
higher exon percentage an interval had, the higher the
number of detected RNA-seq reads in the interval. At 1
Mb interval size, the Pearson’s Correlation Coefficient
between exonic read number and exonic content per-
centage was 0.60; in contrast, the Pearson’s Correlation
Coefficient between intronic read number and exonic
content percentage was only 0.18. The Pearson’s Corre-
lation Coefficient between intergenic read number and
exonic content percentage was also quite low, at 0.26
(Figure 3A and 3B). At 100 kb interval size, the correla-
tion decreased but the general trend was maintained
(Figure 3C). While the exon-rich regions had more
reads for exons than introns or intergenic regions, the
exon-sparse regions had similar numbers of intronic and
intergenic reads as the exon-rich region. In addition, at
1 Mb resolution, the exonic expression level had mod-
estly positive correlation with both intronic (R =0 . 4 3 )
and intergenic expression level (R = 0.37) in the same
region (Additional file 1, Fig. S2 A and B). However, at
100 kb resolution, the aforementioned correlation
became very weak (Additional file 1, Fig. S2 C and D).
Transcriptomic comparison between neural tissues and
other tissues
To understand the neural transcriptome characteristics,
we compared mouse cortical RNA-seq data at E18 and
P7 stages with available adult mouse brain, liver, and
muscle RNA-seq data [18], as well as RNA-seq data
from human embryonic stem cells (hESC) and neural
cells (N1, N2, N3) immediately differentiated from hESC
[7]. We first analyzed transcriptome properties at the
chromosome level, using a method slightly modified
from Mortazavi et al. [18] as detailed in the Methods
section, and labeled as RPKM* (similar to RPKM; for-
mula (1)).
In addition to the above-mentioned mapping of the 5
mouse datasets (E18 and P7 cortices, and adult brain,
liver and muscle), we also mapped the 4 human RNA-
seq datasets (hESC, N1, N2 and N3) onto the mouse
Table 1 RNA-seq mapping result using TopHat
hESC
1
human
embryonic
stem cell
hN1
1
early hESC
initiation
hN2
1
human
neural
progenitor
hN3
1
human
early glial-
like
E18
mouse
brain
cortex at
E18
P7
mouse
brain
cortex at
P7
Adult brain
2
mouse
Adult liver
2
mouse
Adult
muscle
2
mouse
Sequencing
Platform
Illumina
Accession
Number
SRR037165
to
SRR037170
SRR037193
to
SRR037198
SRR037199
to
SRR037205
SRR037220
to
SRR037226
SRP007262 SRP007262 SRR001356
SRR001357
SRR006488 and
SRR006489
SRR001358
SRR001359
SRR006490 and
SRR006491
SRR001361
SRR001362
and
SRR006492
Read Type 35 bp PE and 35 bp SE 36 bp PE and 36 bp SE 33 bp SE
Original
Read Count
14.4 M PE
and 4.4 M
SE
15.8 M PE
and 7.0 M
SE
19.6 M PE
and 11.6 M
SE
22.4 M PE
and 3.0 M
PE
10.0 M PE
and 3.0 M
SE
10.4 M PE
and 3.6 M
SE
89.0 M SE 75.9 M SE 59.9 M SE
Original
RNA-seq
data size
(Mbp)
1,162 1,352 1,774 1,819 853 857 2,936 2,503 1,977
Mapped by
Tophat*
(Mbp)
401 458 628 594 491 525 1,086 683 571
Percentage
Mapped (%)
35 34 35 33 58 61 37 27 29
* Allowing 1 hit by TopHat
1. Data from Wu et al. [7].
2. Data from Mortazavi et al. [18].
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Figure 1 Genome-wide expression map at 1 Mb resolution for E18 and P7. Each 1 Mb interval is represented by a horizontal box, with
color ranging from black to green. A box with black color means that there was no exon in this given interval. The brighter the green color, the
higher the exon content (percentage) this given interval possesses. The scale at the bottom of the map illustrates color representation of the
exon percentage of the region. Red square at the left side of the chromosome represents the detected number of RNA-seq reads for the given
region in E18 stage, while the blue square at the right side represents the detected number of RNA-seq reads in P7 stage. Expression level is
data size normalized. Scale for expression level is at the bottom of the map.
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Page 4 of 22reference genome (mm9 in the UCSC database; [21]).
Based on the 85% identity calculated from coding regions
between mouse and human genome previously [21], there
would be on average 5 mismatches per 35 bp RNA-seq
read length. We found that the threshold of 2 mismatches
per 35 bp read achieved the best balance between specifi-
city and sensitivity for this cross-species mapping. Increas-
ing the number of allowed mismatches resulted in fewer
uniquely and correctly mapped reads, while decreasing
this number resulted in fewer total mappable reads. With
the threshold of allowing maximum 2 mismatches for
RNA-seq mapping, this would mean little cross-species
mappable reads if the differences between coding regions
of human and mouse were distributed evenly. Surprisingly,
on average 6% of the total human RNA-seq reads could be
mapped to the mouse genome, or 11.5% of the reads map-
pable to the human genome. The majority (80%) of the
reads mapped to the mouse genome were also mapped to
the human genome.
We then compared the chromosomal expression pro-
file between mouse (E18, P7, AMB, AMM and AML)
and human (hESC, N1, N2 and N3) samples. Despite
the fact that smaller fractions of the human reads were
mapped onto the mouse reference genome, largely due
to DNA sequence similarity between these two species,
both mouse and human neural data sets were highly
similar in terms of expression level relative to total
mapped reads at the scale of individual chromosomes
(Additional file 1, Fig. S3A). Furthermore, all neural tis-
sues had similar profiles to that of stem cells, but quite
different from those of adult liver and muscle, particu-
larly for some chromosomes, such as 5 and 7 (Addi-
tional file 1, Fig. S3B). To summarize the above
information, we applied Correspondence Analysis on
the chromosomal expression profile. The chromosomal
expression distribution among all stages, using mouse
genome as reference, was first measured in read counts
(Additional file 2, Table S1). Correspondence Analysis
10
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Figure 2 Genomic expression analysis in 10 Kb interval. A. Number of intervals in different categories of RNA-seq read coverage. RNA-seq
reads were categorized as: exonic, which were reads mapped to known exon, intronic, which were reads mapped to known intron, and
intergenic, which were reads mapped to known intergenic region. There were more highly expressed intervals with exonic expression than
intronic or intergenic ones. B. Venn diagram illustration of the above result. Only intervals containing more than 100 reads were considered, as
indicated by the dotted line in A.
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Page 5 of 22(CA) was performed using the ca package in R [22]. The
first two dimensions resulted from the CA could explain
96% of the differences in the original 9 × 21 dimensions,
which indicated that the first two dimensions were
representative (Additional file 2, Table S2). The result
was plotted using these two dimensions (Figure 4). E18
and P7 were clustered together with hESC, N1, N2 and
N3. AMB was also very close to the aforementioned
cluster. AML and AMM were significantly further away
than AMB.
As an alternative way to compare the mouse and human
data, we also mapped the human data onto the human
reference genome (hg19; [23]), for comparative analysis
using previously identified syntenic/orthologous geno-
mic regions between mouse and human [21,23]. These
studies defined 217 conserved syntenic blocks between
the human and mouse genomes. Chromosomal expres-
sion profiles in early-differentiated human neural cells
were very similar to that of human embryonic stem cells
(Additional file 1, Fig. S3C). Even with different chro-
mosome numbers and organizations, neural chromoso-
mal expression profiles were also very similar between
human neural cells and mouse neural tissue samples
between syntenic/orthologous genomic regions (Addi-
tional file 1, Fig. S3B, C). For example, the most highly
expressed chromosome in mouse was chromosome 11,
whose human counterpart is chromosome 17, which
was the second most highly expressed chromosome in
human. The most highly expressed chromosome in
human was chromosome 19, whose mouse counterparts
are distributed on chromosomes 7, 8 and 19, among
which chromosomes 7 and 19 were also highly
expressed in neural tissues.
To assess the variation in expression levels between
chromosomes for different tissues/organs, we calculated
the standard deviation for the distribution of individual
chromosome expression level, or RPKM* values, for
each mapped transcriptome dataset (Additional file 1,
Fig. S3D). We found that the standard deviation for E18
was the lowest among mouse samples, while the stan-
dard deviation for the stem cells was the lowest in
human samples (Additional file 1, Fig. S3D). These
results indicated that the mouse E18 brain cortex and
human embryonic stem cells use chromosomes more
evenly than other organs/tissues.
It is well known that the brain has a very high meta-
bolic rate, consuming a significant amount of energy
0
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Figure 3 Correlation between exon density (measured by
percentage of exon regions) and expression level. A. Interval
size = 1 Mb. Regional percentage of exon vs. exonic expression
(blue diamond), intronic expression (red square), intergenic
expression (green triangle). B. Zoomed in view of the boxed region
in A. C. Interval size = 100 kb. Only data from chromosome 11 were
shown.
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Figure 4 Correspondence Analysis result on stage similarity
based on comparison between chromosomal expression
profiles. Similar stages were closer to each other than dissimilar
ones. Analysis done using ca package in R [22].
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Page 6 of 22while lacking substantial energy reserve tissues. Thus
normal brain functions depend on mitochondria as the
crucial energy provider. To examine the mitochondrial
genome expression-level changes across different devel-
opmental stages, we plotted the normalized mitochon-
drial expression level, measured in RPKM*, across all
nine datasets and normalized against the dataset size.
We found that in human datasets, compared with stem
cells, differentiated neural cells had a higher level of
mitochondrial expression (Additional file 1, Fig. S3E),
increasing from the N1 to N2 stages, then maintaining a
similarly high level at the N3 stage. Similarly in the
mouse brain, mitochondrial expression progressively
increased from the E18 embryonic stage to the P7 neo-
natal stage, then to the adult stage. The adult mouse
brain had a similar level of mitochondrial expression to
that of the adult liver, while the adult mouse muscle
had the highest level of mitochondrial expression among
all analyzed organs/tissues, consistent with high energy
demand for muscle contraction.
To assess the similarity between neural and stem
cell transcriptomes further, we compared the tran-
scriptomes between human and mouse using only 1-
to-1 orthologous gene pairs between these species. A
total of 12168 orthologous gene pairs were identified
using the MGI (http://www.informatics.jax.org) orthol-
ogy database. The expression level of each gene was
measured in RPKM, with the modification that
detected base pairs from exons were used instead of
read number in the RPKM formula to accommodate
read length differences between datasets. Again the
expression level for a given gene at a given stage was
normalized against the RNA-seq dataset size. We then
added 1 to the calculated expression level value for
each gene, to ensure valid logarithm transformation.
The calculated value was then log2 transformed. We
first calculated the gene expression correlation
between hESC and the rest of the samples. As
expected, the correlation was high between hESC and
the cells derived from hESC. Among the rest, E18 had
the highest correlation with hESC (R = 0.61), and P7
had the second highest (R = 0.57). The data were then
analyzed in MeV (MultiExpriment Viewer) from the
TM4 suite [24]. After using different clustering meth-
ods (Hierarchical clustering and K-means) and differ-
ent distance calculation methods (Pearson’s
Correlation and Euclidean Distance), we found that
neural datasets from human and mouse were consis-
tently grouped together with the stem cell dataset,
separate from the liver and muscle datasets (Figure
5A). This suggested that the neural and stem cell
transcriptomes were globally more similar in terms of
orthologous gene expression than they were to liver
and muscle transcriptomes.
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Figure 5 Comparisons of human and mouse expression data.
A. Clustering of nine RNA-seq datasets using orthologous genes
between human and mouse. Center panel: expression level heat
map overview of 12168 orthologous genes. Expression level is
measured in RPKM [18]. The calculated number is increased by 1 to
ensure valid logarithm transformation, and then log2 transformed.
The sample tree on top is derived from Pearson’s Correlation (PC)
distance matrix, while the one at the bottom is derived from
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expression in two different tissues/stages among co-
expressed genes between the tissues/stages (Figure 5B
and Additional file 1, Fig. S6). Among all mouse sam-
ples, although E18 was the one with the highest correla-
tion with hESC, E18 was still more similar to mouse
neural transcriptomes in terms of expression level corre-
lation. In particular, E18 and P7 transcriptomes were
much more correlated with each other than with hESC,
suggesting that the similarity between E18 or P7 cortex
and hESC is relatively limited.
We also analyzed the genes associated with the pluri-
potency of stem cells. Sox2, Myc, Oct4 and Klf4,w h i c h
are four genes that have been found in multiple studies
to convert human and mouse somatic cells to induced
pluripotent stem (iPS) cells [25-29]. Similarly, Oct4 and
Sox2,p l u st w oo t h e rf a c t o r s ,Nanog and LIN28A,w e r e
also able to induce iPS cells from human somatic cells
[30]. We found that Sox2, Myc and Klf4 were detectable
in all neural samples we analyzed (Figure 5A). Specifi-
cally, the E18 stage had the highest Sox2 and Myc
expression among all mouse samples. However, Nanog
and LIN28A were not detected at either the E18 or P7
stage. RT-PCR experiment was also carried out with pri-
mers specifically targeting Sox2, Myc and Klf4.T h e
results supported the expression of Sox2, Myc and Klf4
in E18 and P7 cortices (Figure 6B). Due to the presence
of multiple homologues of Oct4 (also called Pou5f1)i n
the mouse genome, neither RNA-seq nor RT-PCR could
identify specific expression for Oct4/Pou5f1. Interest-
ingly, Sox11, which encodes a transcription factor and
was previously reported to be expressed in glial cells
[31], was highly expressed in the E18 cortex and signifi-
cantly down-regulated in the P7 cortex (Figure 6A
&6B). Because cortical neurons are mainly generated at
the late embryonic stage whereas glial cells are mainly
generated in the postnatal stage, the high level expres-
sion of Sox11 in the E18 cortex suggests an additional
role during early brain development besides its proposed
function in glial cells.
Expression characteristics of genes associated with
neurodevelopmental disorders
We further analyzed the expression of genes potentially
associated with neurodevelopmental disorders in both
neural tissues and stem cells. Autism spectrum disorders
(ASD), together with schizophrenia and mental retarda-
tion, are typically characterized as neurodevelopmental
disorders. Genome-wide association studies (GWAS)
have identified many genes related to ASD. Among
these genes, many have been found to relate to the
GABAergic neurotransmission system. Here, we ana-
lyzed the expression of 20 genes encoding different
GABAA receptor subunits and 25 genes that have been
proposed to be associated with ASD [32,33] (Figure 7A
and 7B). Although GABA receptor genes in general
showed low expression levels in non-neural tissue and
stem cells, the gene for GABAAR alpha5 (GABRA5) sub-
unit showed a very high level of expression in hESCs,
which lacks a GABAergic system, suggesting a novel
function of this gene in embryonic stem cells. Its expres-
sion was not detectable after initial differentiation (N1)
and then observed again after further differentiating into
neural cells (N2). It also showed an increase from E18 to
P7, but a reduction from P7 to adult brain, consistent
with more restricted localization in the adult brain [34].
In addition, GABRQ and GABRP also showed modest
expression in hESCs. Furthermore, the gene encoding the
GABAAR delta (GABRD) subunit showed the highest
expression level among all GABAAR subunit genes in the
adult brain. Since delta is specifically localized at extrasy-
naptic sites and mediates tonic inhibition rather than
normal fast inhibition, this result emphasizes the impor-
tance of tonic inhibition in regulating adult brain activity.
Finally, genes for GABAB receptor (GABBR1 and
GABBR2) subunits showed significant differential expres-
sion during brain development, with GABBR1 dominant
from E18 through adult brain while GABBR2 only
expressed highly in the adult brain.
Among genes associated with ASD, RGS4, DTNBP1,
NLGN2, STX7, MECP2, ARVCF,a n dPPP3CC all
showed high-level expression from the embryonic to
adult brain. One important finding was that while both
NLGN1 and NLGN2 showed high-level expression at
the E18 to P7 stages, consisting with their synaptogenic
functions, NLGN1 expression was significantly reduced
in the adult brain, suggesting that the relevant function
might be fulfilled by other cell adhesion molecules. This
is also consistent with the current understanding that
many cell adhesion molecules can trigger glutamatergic
synapse formation as NLGN1 does, but only NLGN2 is
capable of inducing GABAergic synaptogenesis [35,36].
One surprising finding is that DISC1,aw e l l - s t u d i e d
gene associated with schizophrenia [37], showed very
low expression at the E18/P7 stages and still low in
adult brain. However, DISC1 was modestly expressed in
hESCs and the expression decreased after neural differ-
entiation, suggesting that DISC1 might play an impor-
tant role in stem cell functions.
Euclidean Distance (ED) matrix. Both trees support the same
topology, which grouped all neural stages with stem cell stage,
while left muscle and liver in a separate group. Scale of color
representation of the expression level is at the bottom of the figure.
B. Scatter plot of orthologous gene expression level between
selected stages. Genes without detectable expression were not
included.
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Page 8 of 22Detection of unusually high levels of unannotated
transcript expression level at E18 and P7 stages
To obtain an accurate set of unannotated TARs, we first
subtracted the TARs overlapping with annotated exons,
tRNAs or rRNAs. We then removed TARs overlapping
with repeats. We also excluded TARs within 2 kb vicinity
of the first and last exon to avoid promoter, TSS and TTS
associated transcription activity, which have been pre-
viously studied [38-40]. We call the set of unannotated
TARs generated from the aforementioned procedure the
filtered unannotated TARs, and they include both intronic
TARs and intergenic TARs. We found that the E18 stage
had the highest percentages of both intronic and inter-
genic reads, at 5% and 3% of the E18 total data, respec-
tively (Figure 8A). P7 stage had the second highest
percentages, with about 1.1% and 2.6% for introns and
intergenic regions, respectively. In comparison, almost all
the other datasets had less than 1% of the data matching
intronic or intergenic regions. Among human samples,
surprisingly, the stem cell stage had the lowest percentage
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Figure 6 RNA-seq levels and RT-PCR analyses of pluripotency-related genes. A. Expression level of pluripotency-related genes across stages.
Expression level was measured in both raw RNA-seq data size (bp) and RPKM methods. B. RT-PCR results showing the expression of Sox2, Myc
and Klf4, with Sox11 as the positive control.
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Page 9 of 22of unannotated TARs, while the neural progenitor cell N2
stage had the highest. This result is different from a pre-
vious report [7], which did not use methods that rigor-
ously removed repeats as in this study.
Concordant changes in expression levels between
intronic TARs and flanking exons
To investigate the relationship between an intronic TAR
and its flanking exons, we examined their respective
expression levels (as measured in RPKM; [18]). There
were 488 genes with intronic TARs at either the E18 or
P7 stage. We found a strong positive correlation
between the intronic expression and the flanking exonic
expression. From E18 to P7, we found 436 genes with
decreased intronic expression levels; among these 436
genes, 242 (56%) also had decreased exonic expression
(Table 2). Even more strikingly, 52 genes had increased
intronic expression level from E18 to P7 (Table 2), with
43 (83%) having increased exonic expression levels. The
correlation was highly significant, with a p-value of
0.0001 from Fisher’s Exact Test for the association of
the exonic and intronic expression levels.
Few unannotated TARs were connected with known
exons
The strong concordant correlation between the pre-
viously unannotated intronic TARs and flanking exons
suggested that the intronic TAR and its flanking exon
might be parts of the same RNA transcript. To test
this hypothesis, we focused on the E18 and P7 data-
sets, which had the largest percentage of filtered unan-
notated TARs. A paired-end read with one end located
in the unannotated TAR and the other in a known
exon would be strong evidence that this intronic TAR
a n dt h ek n o w ne x o na r ep a r t so ft h es a m em R N A .
However, it is in principle possible that the mapping
positions could be erroneous. In addition, the existing
mathematical and statistical models for determining
the connection between TARs [8] are designed for
RNA-seq data from cDNAs generated with random
primers. They are not applicable to poly-dT primed
data, which have a 3’ bias. So we first devised a model
suitable for both priming techniques (Methods; for-
mula (2)), which reports the presence of the physical
connection between expressed TARs and known
exons. Using known adjacent exons and single exon
genes (SGEs) with detected reads as positive and nega-
tive controls in a simulation, the formula had success
rates of 93% and 100%, respectively.
U s i n gf o r m u l a2 ,w ef o u n dt h a to n l yav e r ys m a l l
percentage of the unannotated intronic TARs were
connected with known exons (Table 3) as supported
by the RNA-seq reads. Although a large fraction (70%
for E18, 60% for P7) of the unannotated TARs was
found to be connected to other regions mapped else-
where, these mapped regions were very short, fragmen-
ted and unannotated regions with low read coverage.
Surprisingly, some unannotated TARs were connected
to read ends that mapped to multiple chromosomes,
possibly due to mapping to repetitive sequences, erro-
neous mapping or possible cross-chromosome splicing
(trans-splicing), a rare phenomenon that was pre-
viously observed [41].
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Figure 7 Expression of genes associated with neurodevelopmental
disorders. A. Expression of selected GABAA receptor genes. B. Expression
of selected Autism spectrum disorders associated genes.
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Figure 8 Detection of unannotated transcriptionally active regions (TARs). A. Percentage of TAR data of each dataset. Column in red color
represents intronic TAR, and column in blue color represents intergenic TAR. X-axis represents different datasets, while Y-axis represents the
percentage. B to E: An intronic TAR found located inside mouse PCBP2. B: RNA-seq reads mapped by TopHat to this location. Each black bar
represents a RNA-seq read. Because the coverage on the 3’ end (right side) of the gene is too high, only part of the reads mapped at this
region is shown. Each blue horizontal line connecting two bars indicates a splice-junction-spanning read (read split by splicing activity). Red lines
highlighted such reads spanning the intronic TAR and the exon on its left. C: conservation score from 30-Way multi-species genome alignment.
Notice the region with high conservation score co-localized with the intronic TAR. D: current PCBP2 gene model, with green box representing
known exons. E: amino acid alignment of the ORF of intronic TAR and its human and dog homologues. Gray column plot below: each column
represents the similarity of the amino acids in that column. F: RT-PCR validation for intronic TARs. For each intronic TAR inferred from RNA-seq
mapping result, primers were picked to validate the connection between the intronic TAR and the flanking exon (upstream/downstream),
between the flanking exons, as well as the expression of the intronic TAR.
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Page 11 of 22Comparing the intronic TARs with known mRNA and EST
in NCBI databases
To test whether there is other evidence for the intronic
TARs, we searched the data in NCBI’sc D N A / m R N A
and EST databases. Among 554 intronic TARs detected
at E18 stage, 176 (32%) had no matches in NCBI data-
bases. Similarly, among 168 intronic TARs at P7 stage,
49 (29%) had no matches in NCBI databases. Therefore,
our results provide the first evidence for these TARs
being expressed. Among the matching NCBI database
entries, 11 (2%) of the 378 for the E18 stage and 7 (4%)
of the 119 for the P7 stage were from the same stages,
but none of them was from the brain cortex.
We then examined the splicing pattern of the mRNA
and EST records matched to our detected intronic
TARs and found two classes of intronic TARs: (1) with
records suggesting that the TARs were standalone, with-
out connection to known exons; (2) with some records
suggesting that the TARs were standalone while other
records suggesting that they were connected to known
exons. 304 out of 378 (80%) intronic TARs at E18 and
75 out of 119 (63%) intronic TARs at P7 belonged to
the first class. For the second class of intronic TARs, on
average, the ratios for records supporting standalone
transcripts to those for connections to known exons
were 4.2 and 2.8 for the E18 and P7 stages, respectively.
Taking together, the comparison with NCBI’sc D N A /
mRNA and EST databases strongly suggested that most
of our detected intronic TARs were not connected with
known exons and thus were novel transcripts.
Comparing the intronic TARs with known records in
miRbase and lncRNAdb
We then compared our intronic TARs in miRNA data-
base miRbase [42] and long non-coding RNA database
lncRNAdb [43]. Although we found no significant hits
in these two databases for any intronic TARs observed
at P7 stage, we did find 12 and 6 hits for intronic TARs
at E18 stage in miRbase and lncRNAdb, respectively
(Additional file 2, Table S5 and S6). However, all 6
intronic TARs with hits in lncRNAdb were mapped to
t h es a m el n c R N A ,B 2S I N ER N A ,w h i c hw a sf r o ma
SINE repeat element. In addition, 11 of the 12 intronic
TARs having hits in miRbase mapped to the same miR-
1935 miRNA, and the remaining one mapped to miR-
153-2. Otherwise, we did not detect significant hits for
other types of RNAs.
Sequence conservation and coding potential of intronic
TARs
To obtain clues about possible function of the intronic
TARs using sequence similarity to other mammalian
genes, we investigated whether unannotated TARs cor-
responded to any highly conserved region using the 30-
Way Multiz Alignment & Conservation track in UCSC
Genome Browser [44]. We found that there were 554
a n d1 6 8u n a n n o t a t e dT A R sa tE 1 8a n dP 7s t a g e s ,
respectively; among these, 67 in E18 and 21 in P7
matched regions of highly conserved sequences. For
example, a TAR on chromosome 15 (102324092-
102324772) was localized to an intron of the mouse
PCBP2 gene encoding the major cellular poly(rC)-bind-
ing protein [45]. In addition, there were RNA-seq reads
spanning this intronic TAR and the upstream exon (Fig-
ure 8B, red reads), indicating that this previously unan-
noted TAR was spliced with a known exon. Moreover,
this TAR had a significant overlap with a highly con-
served region located in the 3’ most intron, which was
identified by mammalian conservation study using 30-
Way Multiz Alignment & Conservation track data (Fig-
ure 8C and 8D) [44]. An Open Reading Frame (ORF)
was also predicted inside this TAR and was conserved
among the PCBP2 genes of human and dog (99% similar
in amino acid sequences; Figure 7E), but not opossum.
PCR and ABI 3730 resequencing results further verified
that this TAR is indeed part of an mRNA (Figure 8F)
Table 2 Intronic and exonic expression level changes for genes with intronic TARs from E18 to P7
Also With Increased Intronic Expression Also With Decreased Intronic Expression
Number of Genes With Increased Exonic Expression 43 194
Number of Genes With Decreased Exonic Expression 9 242
Table 3 Physical connection between unannotated TARs and known exons
E18 Brain Cortex P7 Brain Cortex
Intronic TAR Intergenic TAR Intronic TAR Intergenic TAR
Connected with Known Exons 19 2 13 2
Not Connected with Known Exons Standalone 117 45 28 41
Non-Standalone (Same Chromosome) 404 71 123 46
Other (Non-Standalone Multi-Chromosome) 1 4 845
Total 554 126 168 94
Sun et al. BMC Genomics 2011, 12:494
http://www.biomedcentral.com/1471-2164/12/494
Page 12 of 22with a connection between this TAR and the upstream
exon, consistent with RNA-seq results. However, PCR
product between this intronic TAR and the downstream
exon was not detected, in agreement with the RNA-seq
results. This TAR was very likely to represent an alter-
native 3’ UTR with a potential coding region.
In addition, an intronic TAR with an ORF inside the
ATP2B1 gene located on chromosome 10 (98481907-
98482067) shares 99.3% identity to the 20
th exon of
human ATP2B1 isoform a (ATP2B1a) (Additional file 1,
Fig. S4). Human ATP2B1 has two splicing variants:
ATB2B1a and ATB2B1b,w h i c hd i f f e ri nt h eu s a g eo f
the 20
th exon. Previous studies showed that ATP2B1a
has a specific expression at synapses whereas ATB2B1b
is expressed in most tissues [45,46]. Thus this TAR is
l i k e l yt oe n c o d ean e u r o n - s p e c i f i ce x o no ft h em o u s e
ATP2B1 gene. We also found another expressed region
on chromosome 7 (112781296-112781396) that shares
87.5% identity with a part of the second 3’ UTR exon of
the human Trim3 gene (Additional file 1, Fig. S4).
Trim3 (or BERP) is expressed in the brain and encodes
a RING finger protein that regulates GABAR cell surface
expression [47]. Another intronic TAR located in the
NRXN1 gene on chromosome 17 (90854147-90854636)
has the potential for coding Neurexin 1, a neuronal cell
adhesion molecule interacting with neuroligins to pro-
mote synapse formation and maturation [48]. The ORFs
in these intronic TARs were highly similar to parts of
human ATP2B1, BERP and NRXN1 genes, respectively.
A number of other intronic TARs, such as those in
CHD3, TSC22,a n dSRCAP, were either similar to
known human exons or supported by mouse gene pre-
dictions and mRNA and/or EST data in the NCBI
database.
Three other intronic TARs were located, respectively,
in the Zeb2 gene on chromosome 2 (44953049-
44955802), the Ntrk3 gene on chromosome 7
(85484006-85485464), and the Odz2 gene on chromo-
some 11 (36491704-36492013), within introns that are
more than 10 kb long. These TARs did not match
mRNA or EST records in the NCBI database, nor were
they similar to protein sequences in the NCBI database.
Nevertheless, these three TARs were conserved in rat,
human, dog and opossum genomes, matching annotated
introns in the orthologous genes in human and rat
(Additional file 1, Fig. S5). Our RNA-seq data did not
detect physical connection between the TARs and
known exons; the lack of connection between the TARs
and the flanking exons were further supported by the
observations that PCR was successful when both pri-
mers were located inside a particular intronic TAR, but
not able to generate products when a primer in the
intronic TAR region was combined with another primer
in one of the flanking exons (Figure 8F). As a control,
the correct PCR product was obtained using primers
matching the two flanking exons of the given intronic
TAR (Figure 8F). Therefore, these three intronic TARs
were most likely standalone transcripts that were not
linked with the flanking exons.
Genes with intronic TARs were over-represented in GO
terms closely associated with neural development
Although we have found that few of these intronic
TARs were physically connected with the exons of the
corresponding genes in the same mRNA, the fact the
same genomic regions encode both the transcripts with
exons and the intronic TARs suggests some association
b e t w e e nt h e s ei n t r o n i cT A R sa n dt h ee x o n i cg e n e s .T o
further examine the functional implication of the intro-
nic TARs, it is informative to study the corresponding
genes. To study the nature of proteins encoded by the
genes with intronic TARs, we analyzed their enrichment
in Biological Process Gene Ontology (GO) using agriGO
[49]. The GO annotations for all expressed genes at
either stage were used as a reference for comparison to
determine possible enrichment of specific GO cate-
gories. A total of 316 unique genes contained filtered
intronic TARs among a total of 10657 genes with
detected reads at E18, while only 119 genes contained
filtered intronic TARs among 10901 genes expressed at
P7. E18 data had 59 statistically overrepresented GO
terms, but P7 data only had 4 statistically overrepre-
sented GO terms, 3 of which are shared between these
stages. The 60 overrepresented GO terms could be
mapped onto only 3 major branches: neural signaling
(Figure 9), neurogenesis (Figure 10) and regulation (Fig-
ure 11). The GO terms of these branches are closely
related with neural developmental events occurring at
E18 stages.
For neural signaling related GO terms at E18, two
subgroups form largely parallel interactions: the first
subgroup mainly functions in regulating neural system
process, while the second subgroup carries out signal
transmission (Figure 9). The terminal node was the reg-
ulation of synaptic transmission, which combines the
aforementioned two functions. Among the nodes with
strong statistical support were “transmission of nerve
impulse”, “neurological system process”,a n d“synaptic
transmission”. Another interesting aspect is that the reg-
ulatory relations in the first subgroup were positive,
w h i l et h e yw e r en e g a t i v ei nt h es e c o n ds u b g r o u p .F o r
neural signaling related GO terms at P7, however, only
one function group, similar to the aforementioned 2
nd
subgroup, was identified. It had 3 nodes and the regula-
tory relations between the nodes were negative (Figure
9).
Nearly half (28, all at E18) of the enriched GO terms
were for neurogenesis, with extensive interconnections
Sun et al. BMC Genomics 2011, 12:494
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Page 13 of 22between nodes and no obvious functional subgroups
(Figure 10). The functions of these nodes include many
aspects of neural development, such as cell morphogen-
esis, neurogenesis and neuron differentiation, eventually
diverging into two termini: (1) axongenesis and axon
guidance and (2) dendrite morphogenesis. It is also
striking that all regulatory relationships were negative.
As shown in Figure 10, the third major group of over-
represented GO terms at E18 was for regulation. They
were mainly about negative regulations, consistent with
the negative regulatory relations identified between the
majority of the nodes for neural signaling and neurogen-
esis groups. Specifically, strong statistical support was
found for negative regulation of “metabolic process”,o f
“gene expression” and of “biosynthetic process”,e n d i n g
in that of RNA polymerase II-dependent transcription.
For P7, only one node received strong statistical sup-
port: regulation of molecular function (Figure 11).
Because axon guidance is critical for correct formation
of the neural circuit during neural development, we
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Page 14 of 22then further analyzed the axon guidance node at E18. A
total of 10 genes with filtered intronic TARs were
assigned to this node by GO. According to the KEGG
Pathway database [50], among the 10 genes, Robo1,
Robo2, Nrp1, Dcc, Ephb1 and Ephb2 were all receptors
involved in axon guidance pathway. They were all
involved in the regulation of the cytoskeleton dynamics
and axon repulsion activity. The average ratio of intro-
nic read number to exonic read number for these 10
g e n e sw a s3 . 9a tE 1 8 ,b u tw a s1 . 8a tP 7( T a b l e4 ) .A sa
comparison, we also examined three well-known genes:
Myc, b-actin (Actb) and tubulin (Tuba1a), and found
that their expression levels (exonic reads) were very
similar between E18 and P7. However, the average ratios
of intronic read number to exonic read number for
these three genes were 0.023 and 0.051 at E18 and P7,
respectively. These ratios were less than 1/100 (E18) or
1/30 (P7) of those for the 10 axon guidance associated
genes. From a different perspective, for the 10 axon
guidance associated genes, the average exonic reads
ratio (E18/P7) was 1.61, suggesting a slight reduction in
expression. In contrast, while the average intronic reads
ratio (E18/P7) was 3.67, representing a much bigger
reduction of the intronic transcripts. As a reference, the
3h o u s ek e e p i n gg e n e sh a da na v e r a g er a t i oo f1 . 0 9f o r
E18/P7 exonic reads, whereas the intronic read numbers
for the 3 genes were too low to compare accurately.
Therefore, the 10 axon guidance-related genes had sig-
nificantly more intronic reads than exonic reads (P-
value = 0.001, Chi-square with Yates correction) and
more so at E18 than P7 (P-value = 0.001), suggesting a
possible role of these intronic transcripts in modulating
axon guidance at E18 cortex. Conclusions
Neural and stem cell transcriptome
In this study, we have investigated global characteristics
of embryonic and neonatal neural transcriptomes, and
compared with transcriptomes of the adult brain and
E18
GO:0032502
(1.26e-06)
developmental
process
GO:0007275
(2.18e-06)
multicellular
organismal
development
GO:0048856
(1.06e-06)
anatomical
structure
development
GO:0048869
(0.00174)
cellular
developmental
process
GO:0009653
(0.00287)
anatomical
structure
morphogenesis
GO:0048731
(3.45e-06)
system
development
GO:0048513
(0.00276)
organ
development
GO:0007399
(2.56e-08)
nervous
system
development
GO:0032989
(0.00185)
cellular
component
morphogenesis
GO:0030154
(0.00199)
cell
differentiation
GO:0007417
(0.000439)
central
nervous
system
development
GO:0032990
(0.0021)
cell part
morphogenesis
GO:0000902
(0.00152)
cell
morphogenesis
GO:0022008
(1.14e-06)
neurogenesis
GO:0048468
(0.000279)
cell
development
GO:0006928
(0.00542)
cellular
component
movement
GO:0048812
(0.00221)
neuron projection
morphogenesis
GO:0048858
(0.0034)
cell projection
morphogenesis
GO:0000904
(0.0121)
cell
morphogenesis
involved in
differentiation
GO:0048699
(5.97e-06)
generation
of neurons
GO:0030182
(3.28e-05)
neuron
differentiation
GO:0048666
(0.000522)
neuron
development
GO:0048667
(0.00182)
cell
morphogenesis
involved in
neuron
differentiation
GO:0007411
(0.0269)
axon guidance
GO:0007409
(0.00278)
axongenesis
GO:0048813
(0.0124)
dendrite
morphogenesis
GO:0016358
(0.000143)
dendrite
development
GO:0031175
(0.00739)
neuron projection
development
Significance
Level
Relationship
Indicator
significant
extremely
significant
not
significant
is_a
part_of
positive_regulate
negative_regulate
only one node is significant
Figure 10 Neurogenesis GO terms significantly overrepresented by genes with intronic TARs. The coloring of the node box indicates the
statistical support for the overrepresentation. The color scale at the bottom of the figure illustrates the different levels of statistical support. The
node box with white color means that that node was not statistically overrepresented. However these are included to illustrate the relationship
between statistically significant nodes.
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Page 16 of 22embryonic stem cells. We found that embryonic and
neonatal brain cortex transcriptomes correspond to
most genomic regions at large scale of megabase inter-
vals, but are unevenly distributed with positive correla-
tion to exon density. In addition, neural transcriptomes
are similar to that of embryonic stem cells, more than
those of liver and muscle, in several features including
chromosome level expression (Additional file 1, Fig. S3A
and B), and expression pattern of orthologous genes
(Figure 5). Also, the E18 brain cortex transcriptome and
hESC transcriptome showed relatively even chromoso-
mal distribution and had lower mitochondrial
expression.
Other than these global similarities, we noted another
shared characteristic between neural expressed genes
and genes important for pluripotent stem cells. Specifi-
cally, three genes, Sox2, Myc and Klf4 were detectable in
all six neural samples (Figure 6), with high levels in E18
or P7 transcriptomes. The expression of these genes
suggests that neural cells might need fewer factors to be
converted to stem cells. Indeed Kim et al found that
only two factors (Oct4 with either Klf4 or c-Myc),
instead of four, were needed to revert neural stem cell
to iPS cells [51]. Therefore, the similarity in transcrip-
tome, including the expression of specific genes, such as
Sox2, Myc and Klf4, between neural cells and stem cells
suggests that neural cells might retain certain stem cell
properties and have greater potential to be repro-
grammed to be pluripotent.
Intronic TARs as standalone RNA regulators in early brain
development
The mapping results of our transcriptome datasets
revealed significant levels of intronic reads. We found
that only a small portion of the intronic transcripts that
we detected was on the same RNAs with any known
exons. Recently, Klevebring et al. have reported that
about 50% of the intronic expression was actually from
the antisense strand [11], different from the sense exon-
containing mRNAs of the same gene. Thus the intronic
TARs detected here share some characteristic with the
antisense transcripts, although our data lacked the
strand information. Our finding that the level of intronic
transcript is positively correlated with that of flanking
exons is consistent with previous studies that antisense
transcription may have both concordant and discordant
regulation relative to the adjacent exons [3]. Further-
more, Faghihi et al. also reported regulation involving
antisense RNA not mediated by the conventional RNA
interference pathway [52], indicating additional mechan-
isms are important. Our results that the E18 brain cor-
tex has significantly higher levels of intronic transcripts
Table 4 Exonic and intronic RNA-seq read number comparison between E18 and P7 for exon guidance related genes.
Gene Name Number of detected reads in E18 Number of detected reads in P7
From Exon From Intron From Exon From Intron
Slit3 43 1012 96 827
Robo2 2123 4900 1415 796
Robo1 1569 1872 425 362
Nrp1 991 1688 533 416
Nrcam 775 1150 1434 730
Klf7 1032 826 1088 328
Gli3 295 133 83 51
Ephb2 697 845 548 456
Ephb1 2006 1773 834 435
Dcc 1294 6509 281 1246
Read Ratio (Intron/Exon) 3.860 1.802
Intronic Read Ratio (E18/P7) 3.67
Exonic Read Ratio
(E18/P7)
1.61
Myc 358 13 229 8
Actb 8847 144 8236 503
Tuba1a 4029 63 3724 214
Read Ratio (Intron/Exon) 0.023 0.051
Intronic Read Ratio (E18/P7) 0.30
Exonic Read Ratio
(E18/P7)
1.09
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Page 17 of 22than other tissues/organs strongly suggest that such
non-coding transcripts play important roles in regulating
gene expression during embryonic brain development.
We also found that the mouse E18 embryonic brain
had a concordant relation between intronic transcript
and flanking exonic expression. This is unlike previous
studies showing preferential localization of antisense
transcripts in the upstream and downstream regions of
the gene [53-55]. Our data have further indicated that
the E18 embryonic brain showed enrichment of genes
with intronic TARs in GO categories that are closely
associated with neural functions. The E18 cortical neu-
rons are actively engaged in neurogenesis, including
axonogenesis and synaptogenesis. For the significant GO
terms associated with neurogenesis, all the regulatory
relations between nodes were negative (Figure 10).
Moreover, an entire group of significant nodes was
about negative regulation (Figure 11). However, at P7,
intronic TARs were no longer associated with either
neurogenesis or negative regulation. These findings sug-
gest the involvement of intronic TARs in stage-specific
regulation of neural developmental.
Recently, a subset of long ncRNAs was found to have
an enhancer-like function [56]. Our data also indicated
a correlation between the change in intronic transcript
expression level and the change in the expression level
of the corresponding gene. For example, the increased
intronic expression is correlated with increased exonic
expression for 10 axon guidance associated genes,
whereas such correlation was not found for a control set
of 3 housekeeping genes. The positive correlation in
expression change between intronic TARs and the flank-
ing exons further supports the idea that they have regu-
latory interactions, although it is formally possible that
the intronic transcripts have functions unrelated to the
genes represented by the flanking exons.
Our transcriptome analyses have revealed possible
important mechanisms for gene function and its regula-
tion in the developing brain, and uncovered a strong
similarity to stem cells. These results provide a number
of novel insights regarding neural developmental gene
functions that can be further investigated using molecu-
lar genetic, biochemical and electrophysiological
experiments.
Methods
RNA-seq mapping
RNA-seq data for hESC, N1, N2 and N3 were obtained
from NCBI Sequence Read Archive SRP002079. RNA-
seq data for adult mouse brain, liver and muscle tissues
were obtained from NCBI Sequence Read Archive
SRA001030. RNA-seq data for mouse embryonic day 18
and postnatal day 7 brain cortices were the same as
described previously [9]. Its NCBI Sequence Read
Archive accession number is SRP007262. The protocol
for dissection of the mouse cortex was approved by
IACUC committee of Pennsylvania State University and
in accordance with the US Federal guidelines. All quality
scores were then transformed into FASTQ ASCII code
by original quality score plus 64. TopHat was selected
for mapping these RNA-seq data. SRP002079 data were
mapped onto human genome (UCSC hg19, NCBI Build
37), and the rest were mapped onto mouse genome
(UCSC mm9, NCBI Build 37), both with the following
parameters: –solexa-qual, -g 1. The same parameters
were used when we mapped all nine datasets onto
mouse reference genome. Although TopHat was
instructed to report only unique hit (-g 1), it sometimes
could not fully suppress multiple hits (personal commu-
nication with Cole Trapnell, TopHat author, on Feb
22
nd 2011). Results were then further screened against
RepeatMasker [57] database of the corresponding spe-
cies to further eliminate possible ambiguous hits.
Normalizing against data size and chromosome size
Normalization was done according to previously pub-
lished RPKM method [18] with the following adjust-
ment: length normalization was done against
chromosome size LC when we were studying the chro-
mosomal expression level distribution. Also, unlike the
original RPKM concept, detected base pair size Cbp was
used instead of read numbers to accommodate different
read-lengths from different RNA-seq datasets (33 bp, 35
bp and 36 bp). For the same reason, total mapped base
pairs Nbp was used in normalization against data size.
And thus the RPKM* label was used here to distinguish
these differences:
RPKM∗ =
Cbp × 1012
Nbp × LC
(1)
Data size normalization was done against mappable
data size instead of original data size generated from
sequencer. This was to accommodate systematic
sequence quality and mapping percentage differences
from different datasets.
Unannotated transcriptionally active region (TAR) calling
After the RNA-seq data were mapped to the target gen-
ome, regions with continuous read coverage that were
within close proximity to each other were then chained
together, thus forming the transcriptionally active
regions (TARs). Only TARs longer than 100 bp and
with more than 5X coverage were considered. These
TARs were then compared with UCSC Known Gene
[ 5 8 ] .T A R st h a td i dn o to v e r l a pw i t hU C S CK n o w n
Gene annotation features were then compared with
known tRNA annotation [59] and custom-complied
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Page 18 of 22rRNA annotation. To further eliminate possible false-
positives from repeat, TARs that were not included in
any of the above annotations were then mapped back to
genome with BLAST [60]. All regions with significant
hits elsewhere in the genome were discarded. The
remaining unannotated TARs were then filtered by their
distance to their nearest exons. All unannotated TARs
that were too close to known exons or genes were dis-
carded as these may originated from previously reported
small exon variations [61].
RT-PCR validation for intronic TARs and the connection
between intronic TARs and flanking exons
Sample preparation and RNA extraction were done
according to the procedures described previously [9].
For the RT-PCR experiment, total RNA was isolated
from mice E18 and P7 cortical tissues by using Ambion
RNAqueous-Midi Total RNA Isolation Kit (Cata-
log#1911). One microgram of RNA was reverse tran-
scribed into cDNA by using Biolabs DyNAmo cDNA
Synthesis Kit (Catalog# F-470L).
To validate the expression of several pluripotency-
related genes: approximately 1/20 of the first strand
cDNAs was used as a template for PCR with gene-speci-
fic primers. PCR was carried out for 25 cycles of 94°C
for 20s, 54°C for 30s, and 74°C for 40s. 10 ul of PCR
products was separated on 0.8% (w/v) agarose gels con-
taining ethidium bromide and visualized by UV light. A
secondary PCR was performed for P7 with same primers
by using 1 ul first round PCR products, for 32 cycles.
To validate the expression of specific intronic TARs,
primer sequences were chosen within the intronic TAR,
between the intronic TAR and the upstream exon,
between the intronic TAR and the downstream exon,
and between the upstream exon and the down stream
exon. RT-PCR was carried out using the cDNAs as tem-
plate with Taq polymerase for 22 cycles (add the tem-
perature info). PCR product was sequenced at the
Genomics Core Facility at Penn State using an ABI
3730 machine.
Models to determine the physical connection of
unannotated TARs with known exons/transcript for both
poly-dT and random primed RNA-seq data
The general question can be abstracted to how to deter-
mine whether a given detected transciptionally active
region (TAR) was on the same RNA with other exons/
transcripts using paired-end information, i.e., there was
a physical connection between the given TAR and
another exon. If a given unannotated TAR is long and
has many internal RNA-seq reads, its number of paired-
end reads with one end located at a known exon should
mean differently if a given unannotated TAR is short
and with comparably less internal RNA-seq reads. We
thus propose that the support for the aforementioned
physical connection between the unannotated TAR and
a known exon should be evaluated as a function of the
length of the given unannotated TAR, the coverage
(number of internal RNA-seq reads) of the unannoated
TAR and the number of paried-end RNA-seq reads link-
ing this unannotated TAR and another known exon.
RNA-seq mappers also tend to have a lower mapping
capability if they need to map a partial read at the end
of an exon or TAR.
We first assumed that the paired-end read distribution
inside a given TAR were either in a uniform distribution
(in the case of using random primer), or in a skewed
distribution (in the case of using ploy-T primer). Under
this assumption, if the given TAR was part of a larger
transcript, the number of paired-end reads at its end(s)
should be similar to the average number of paired-end
reads over the entire TAR. The following formula was
used to calculate the estimated number of paired-end
reads (Ne)a to n l yo n ee n do ft h eg i v e nT A R ,o nt h e
assumption that this TAR was part of a larger transcript:
Ne =
Ni × Lc
2 × Lr
−
T × Ni × (Ls − M)
Lr
(2)
Ni, two times the total number of paired-end reads
with both ends located inside the given region (to reflect
each end in a pair).
Ls, read length for one end of a paired-end read.
Lc, clone length of a paired-end read, which is 2×Ls
plus the insert size.
Lr, length of the given TAR.
M, maximum number of allowed mismatches of the
mapping algorithm.
T, a correction factor. Splice junction spanning reads
will have two partial matches to two discrete genomic
regions. This value represents the success rate of the
algorithm in mapping partial reads to the end of a given
region, normally between 0 and 1. 0 means the algo-
rithm cannot map partial reads to the end of a given
region. 1 means the algorithm can map 100% of the par-
tial reads to the end of a given region. Given the fact
TopHat is designed to do RNA-seq mapping, the T
value we picked was 0.99.
If data indicated that there was a significant amount of
links from the given TAR to both upstream and down-
stream exons, the Ne should be doubled since there
should be reads covering both ends of the given TAR. If
the size of the given region Lr was smaller than that of
the clone length Lc, then by theory all paired-end reads
from this TAR should be reads linking this given TAR
with other region(s).
If the actual number of paired-end reads connecting a
given TAR with other regions was significantly less than
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Page 19 of 22(in this case we used 20%) Ne, the given TAR is thought
to be a standalone transcript. Otherwise, this region was
inferred as non-standalone, which means some level of
splicing activity. More specifically, if a significant portion
of the aforementioned paired-end reads had the other
ends located in annotated exon(s), this given TAR was
thought to be part of a known transcript. However, if
the aforementioned reads were connecting more than
one chromosome, then this TAR was thought to be
multi-chromosome linked.
Testing model effectiveness
To test the effectiveness of the proposed formula (for-
mula (2)) in determining the connection between a
given unannotated TAR and known exon(s), we must
have positive controls that are known to be detectable
in our dataset and are also known to be on the same
R N A sw i t hk n o w ne x o n s .A ne x p r e s s e de x o nf r o ma
multi-exon gene would meet this requirement and
should be able to serve as our positive control. To
ensure that these exons were truly connected to known
exons by RNA-seq reads, these exons were selected by
hand through manual inspection of the RNA-seq map-
ping results using Integrative Genomics Viewer (IGV,
http://www.broadinstitute.org/igv). For each selected
exon, we made sure that there were multiple reads
spanning the selected exon with at least one other
k n o w ne x o n .T oe n s u r eat r u er e p r e s e n t a t i o no ft h e
genome wide situation from our test data, these selected
exons were picked from different chromosomes, with
different RNA-seq read coverage, different locations
within a given gene and different relative distances to
the 3’ end (Additional file 2, Table S3). The proposed
formula (formula (2)) was able to identify such exons as
being physically connected with known exons with a
success rate of 93%.
We also performed a negative control test to deter-
mine the effectiveness of the proposed formula in deter-
mining whether a given transcript has a physical
connection with any known exon(s). Single exon genes
(SEGs) in mouse genome were selected as the negative
c o n t r o l ss i n c et h e ya r ek n o w nt ob eas t a n d a l o n et r a n -
script. We first identified a list of SEGs which had
RNA-seq reads in our dataset (Additional file 2, Table
S4). The proposed formula was able to identify these
selected SEGs as not being physically connected with
any known exon(s) at a success rate of 100% (14% of
the selected SEGs were determined, however, as multi-
chromosome linked).
Gene Ontology (GO) analysis
Reference mouse GO annotation was obtained from the
Jackson Laboratory’s MGI site (http://www.informatics.
jax.org). Expressed genes were inferred from RNA-seq
mapping results mapped to UCSC Known Gene.
Expressed genes were then compared with reference
mouse GO annotation. Identifier conversion between
the UCSC Known Gene and the GO annotation was
done using in-house script. Among all GO terms, only
Biological Process GO terms were analyzed. We first
calculated the number of genes mapped to a given GO
term. For a gene with multiple GO terms, all terms
were considered because one gene may be involved in
multiple biological processes. If one GO term node was
counted, all its parental nodes were excluded. Four sets
of GO annotation were produced using the aforemen-
tioned procedure: all expressed genes in E18, all
expressed genes in P7, genes with intronic TAR(s) in
E18 and genes with intronic TAR(s) in P7.
For a given stage, GO annotation for the entire tran-
scriptome and GO annotation for only genes containing
intronic TARs were compared using agriGO server [49].
The statistical significance was determined by Fisher’s
Exact Test, with Bonferroni Correction. The p-value
threshold was preset at 0.05 and only GO terms with
more than 5 hits were reported.
Accession Numbers
Human samples: [SRA: SRP002079], adult mouse sam-
ples: [SRA: SRA001030], brain cortices samples: [SRA:
SRP007262].
Additional material
Additional file 1: this file includes figure S1 to S7.
Additional file 2: this file includes supplemental data and analysis
results relevant to this study, table S1 to S6, and figure legends for
figure S1 to S7.
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